Sci Rep. 2016 Oct 7;6:34857. doi: 10.1038/srep34857.

Lipid metabolism is associated with developmental epigenetic programming.

Marchlewicz EH¹, Dolinoy DC^1,2,3, Tang L⁴, Milewski S⁵, Jones TR¹, Goodrich JM¹, Soni T⁶, Domino SE⁷, Song PX⁴, F Burant C^2,6,8,9, Padmanabhan V^1,3,5,7,9.

Abstract

Maternal diet and metabolism impact fetal development. Epigenetic reprogramming facilitates fetal adaptation to these in utero cues. To determine if maternal metabolite levels impact infant DNA methylation globally and at growth and development genes, we followed a clinical birth cohort of 40 mother-infant dyads. Targeted metabolomics and quantitative DNA methylation were analyzed in 1st trimester maternal plasma (M1) and delivery maternal plasma (M2) as well as infant umbilical cord blood plasma (CB). We found very long chain fatty acids, medium chain acylcarnitines, and histidine were: (1) stable in maternal plasma from pregnancy to delivery, (2) significantly correlated between M1, M2, and CB, and (3) in the top 10% of maternal metabolites correlating with infant DNA methylation, suggesting maternal metabolites associated with infant DNA methylation are tightly controlled. Global DNA methylation was highly correlated across M1, M2, and CB. Thus, circulating maternal lipids are associated with developmental epigenetic programming, which in turn may impact lifelong health and disease risk. Further studies are required to determine the causal link between maternal plasma lipids and infant DNA methylation patterns.